THERALASE® TECHNOLOGIES

Stock Information

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the
  • TSX Venture Exchange (TLT: TSXV)
  • TLTFF: OTCQB

Data last updated on February 8, 2024

Number of common shares outstanding

Shares Outstanding: 228,460,858

Warrants: 80,524,017

Stock Options: 18,510,000

 

 

For Investor Relations please contact: Investor Information Theralase®

Our Partners

As part of our continuing mission to design, develop, and manufacture cutting-edge laser technologies, Theralase® has partnered with individuals and groups at the following institutions and organizations.

University Health Network
Virginia Tech
nova scotia health authority
curc
McGill University
nova scotia health authority
university of manitoba
Virginia urology
midlantic urology
urology associates
london health science
phac